Indian pharma tycoon gets nod to buy major stake in Suzlon

Academics criticise SBTi's 'arbitrary and restrictive' approach

The Science Based Targets initiative (SBTi) has been criticised by a group of academics for taking a "prescriptive" approach to emissions reductions and carbon offsets.

Macquarie-led consortium acquires remaining stake in UK's National Gas

Bpifrance, Zebra Impact leads €27m funding in resistant weed biotech

Judging the credibility of transition plans, part one

Investors preparing for a wave of transition plan disclosures face a complicated task to determine 'what good looks like', Michael Hurley writes

People Moves, 26 July: Greenbank, Moody's LSEG, Cbus ... and more